Vinge has advised Dianovator AB in connection with a directed share issue to finance the company’s research and development.
Dianovator AB is developing a patient-specific decision support system for improved glycemic control by optimized insulin dosing.
Dianovator AB was assisted by Kristoffer Franzkeit.